Pathology, pathophysiology, and treatment strategies of endocrine disorders and their cardiac complications

被引：2
作者：
Luk, Adriana [1 ]
Ezzat, Shereen [2 ]
Butany, Jagdish [3 ,4 ]
机构：
[1] Toronto Gen Hosp, Univ Hlth Network, Dept Med, Toronto, ON M5G 2C4, Canada
[2] Princess Margaret Hosp, Univ Hlth Network, Dept Med & Endocrine Oncol, Toronto, ON M4X 1K9, Canada
[3] Toronto Gen Hosp, Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2C4, Canada
[4] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada
来源：
SEMINARS IN DIAGNOSTIC PATHOLOGY | 2013年 / 30卷 / 03期
关键词：
Thyroid disease; Calcium disorders; Disorders of glucocorticoid; metabolism; Diabetes mellitus; Acromegaly; Carcinoid heart disease; BETA-ADRENERGIC RESPONSIVENESS; CARCINOID HEART-DISEASE; THYROID-HORMONE; PRIMARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; SUBCLINICAL HYPOTHYROIDISM; POSTMENOPAUSAL WOMEN; BLOOD-PRESSURE; GROWTH-HORMONE; MYOCARDIAL-INFARCTION;
D O I：
10.1053/j.semdp.2013.06.008
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
The cardiovascular system is affected by a multitude of endocrine disorders, including dysfunction of the thyroid, calcium, glucocorticoids, insulin/glucose, and growth hormone axes. Since most of these changes in the cardiovascular system are reversible when treated, early diagnosis is important, as if left untreated, they may become fatal. This review focuses on the pathophysiology, clinical presentation, pathology, and treatment of patients with these endocrine diseases who present with a variety of cardiovascular manifestations. Neuroendocrine tumors presenting with the carcinoid syndrome and their cardiovascular manifestations are also discussed. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码：245 / 262
页数：18
相关论文
共 176 条
  • [1] Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
    Adler, AI
    Stratton, IM
    Neil, HAW
    Yudkin, JS
    Matthews, DR
    Cull, CA
    Wright, AD
    Turner, RC
    Holman, RR
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258): : 412 - 419
  • [2] American Diabetes Association, 2008, DIABETES CARE, V25, P202
  • [3] HYPERINSULINEMIA PRODUCES BOTH SYMPATHETIC NEURAL ACTIVATION AND VASODILATION IN NORMAL HUMANS
    ANDERSON, EA
    HOFFMAN, RP
    BALON, TW
    SINKEY, CA
    MARK, AL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (06) : 2246 - 2252
  • [4] Primary hyperparathyroidism and heart disease - a review
    Andersson, P
    Rydberg, E
    Willenheimer, R
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (20) : 1776 - 1787
  • [5] [Anonymous], 2008, CAN J DIABETES
  • [6] *ANT TRIAL COLL, 1998, BMJ-BRIT MED J, V296, P320
  • [7] Diagnosis and complications of Cushing's syndrome: A consensus statement
    Arnaldi, G
    Angeli, A
    Atkinson, AB
    Bertagna, X
    Cavagnini, F
    Chrousos, GP
    Fava, GA
    Findling, JW
    Gaillard, RC
    Grossman, AB
    Kola, B
    Lacroix, A
    Mancini, T
    Mantero, F
    Newell-Price, J
    Nieman, LK
    Sonino, N
    Vance, ML
    Giustina, A
    Boscaro, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (12) : 5593 - 5602
  • [8] The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy
    Asbun, J
    Villarreal, FJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 693 - 700
  • [9] Type 1 diabetes: new perspectives on disease pathogenesis and treatment
    Atkinson, MA
    Eisenbarth, GS
    [J]. LANCET, 2001, 358 (9277) : 221 - 229
  • [10] Subclinical hyperthyroidism as a risk factor for atrial fibrillation
    Auer, J
    Scheibner, P
    Mische, T
    Langsteger, W
    Eber, O
    Eber, B
    [J]. AMERICAN HEART JOURNAL, 2001, 142 (05) : 838 - 842
12345678910